Effectiveness of weight loss in the treatment of non-alcoholic steatohepatitis in an obese adolescent;Eficacia de la reducción de peso en la curación de la esteatohepatitis no alcohólica en un adolescente obeso

Anales de Pediatria

Volumn 66, Issue 2, 2007, Pages 184-187

  Cavanilles Walker, E ^a   Solar Boga, A ^a   Garcia Alonso L ^a   Lorenzo Patino M J ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Children; Diet; Non alcoholic fatty liver disease; Obesity; Steatohepatitis

Indexed keywords

AEROBIC EXERCISE; ARTICLE; CASE REPORT; DISEASE COURSE; HISTOLOGY; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; SCHOOL CHILD; WEIGHT REDUCTION;

EID: 33947358110     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13098938     Document Type: Article

References (20)

1. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004;8:549-58.
2. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vicenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr. 1994;125:239-41.
3. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48-53.
4. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 2001; 7:608-14.
5. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154-60.
6. American Academy of Pediatrics. Policy Statement. Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics. 2003;112:424-8.
7. Brunt EM. Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis. 2001;21:3-16.
8. Marceau P, Biron S, Hould F-S, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513-7.
9. Kerkar N. Non-alcoholic steatohepatitis in children. Pediatr Trasplantation. 2004;8:613-8.
10. Lavine JE. Vitamine E treatment of nonalcoholic steatohepatitis in children: A pilot study. J Pediatr. 2000;136:734-8.
11. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough J. Clinical features and natural history of nonalcoholic steatosis syndromes. Sem Liver Dis. 2001;21:17-26.
12. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450-5.
13. Chitturi S, Abeygunasekera S, Farell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistanse: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35:373-9.
14. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997;42: 1428-32.
15. Strauss RS, Barlow SE, Dietz WH. Prevalence of anormal serun aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136:727-33.
16. Roberts EA. Steatohepatitis in children. Best Practice & Research Clinical Gastroenterology. 2002;16:749-65.
17. Fishbein MH, Miner M, Mogren C, Chalekson J. The spectrum of fatty liver in obese children and the relathionship of serum minotransferases to severity of steatosis. J Pediatr Gastroenterol Nutr. 2003;36:54-61.
18. Roberts EA. Nonalcoholic steatohepatitis in children. Current Gastroenterology Reports. 2003;5:253-9.
19. Spieth LE, Harnish JD, Lenders CM, Raezer LB, Pereira MA, Hagen SJ, et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med. 2000;154:947-51.
20. Vajro P, Franzese A, Valerio G, Iannucci MP, Aragione N. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr. 2000;136:739-43.